Skip to main content
. 2021 Mar 5;8(3):e20036. doi: 10.2196/20036

Table 4.

Pretreatment and posttreatment assessment for PHQ-9, GAD-7, and EQ5D5L.

Variable T0, mean (SD) T1, mean (SD) t (df)/Z P value Effect size (g) 95% CI
PHQ-9a 9.46 (3.59) 5.54 (3.21) 6.75 (49)b <.001 1.15 2.75-5.1
GAD-7c 7.54 (3.8) 4.2 (2.65) –4.22d <.001 1.02 2.06-4.61
EQ5D5Le 0.83 (0.10) 0.88 (0.10) –2.66d .008 0.50

aPHQ-9: 9-item Patient Health Questionnaire.

bPaired sample test.

cGAD-7: 7-item Generalized Anxiety Disorder.

dWilcoxon signed-rank test.

eEQ5D5L: Euro Quality of Life 5 Dimension-5 Level Scale.